Question 1

What is LOPJLB’s current signal on GRCE?

Accepted Answer

LOPJLB’s latest quantitative signal on Grace Therapeutics, Inc. (GRCE) is SELL in a RECOVERY regime. Signals are updated daily.

Question 2

What market regime is GRCE in?

Accepted Answer

Grace Therapeutics, Inc. (GRCE) is currently classified in the RECOVERY HMM market regime on LOPJLB.

Question 3

What does Grace Therapeutics, Inc. (GRCE) do?

Accepted Answer

Grace Therapeutics, Inc. specializes in the creation and commercialization of pharmaceutical products, primarily targeting uncommon and neglected diseases, with operations centered in Canada. The company's most advanced experimental treatment is GTX-104, an intravenous infusion designed to address subarachnoid hemorrhage. Its development pipeline further includes GTX-102, an oral mucosal betame…

Question 4

Where is Grace Therapeutics, Inc. based / listed?

Accepted Answer

Grace Therapeutics, Inc. is based in US, listed on NASDAQ.

Grace Therapeutics, Inc. (GRCE)

Key stats

Prediction markets

Company news